EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOKIG00005012341
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOKIG00005001923
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

26s Proteasome Complex Subunit Sem1-Like

Ensembl ID : ENSOKIG00005021358
Gene Symbol: LOC109903378
3 Cross references
149 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 1-Like

Ensembl ID : ENSOKIG00005019959
Gene Symbol: LOC109902257
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSOKIG00005050034
Gene Symbol: LOC109870083
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b-Like

Ensembl ID : ENSOKIG00005010937
Gene Symbol: LOC109865405
3 Cross references
214 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 13-Like

Ensembl ID : ENSOKIG00005019710
Gene Symbol: LOC109886365
3 Cross references
215 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14

Ensembl ID : ENSOKIG00005017263
Gene Symbol: LOC109890595
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 14

Ensembl ID : ENSOKIG00005050675
Gene Symbol: LOC109890595
3 Cross references
207 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSOKIG00005012420
Gene Symbol: LOC109905793
3 Cross references
218 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSOKIG00005012883
Gene Symbol: LOC109880879
3 Cross references
217 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6

Ensembl ID : ENSOKIG00005025959
Gene Symbol: LOC109891014
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).